chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Inconsolable screaming for several hours, red splotches on legs for several hours, refused to eat for 2 weeks, vomited for several days, eczema developed all over body which is still there 6 years later
Immediately noted arm heaviness after injection, by night arm increasingly painful with sl. limitation in ROM around shoulder. Also c/o nausea (resolved) dizziness/fatigue. Pain radiating to back and both legs in office.
ON APRIL 10, THE PATIENT RECEIVED A SHINGRIX VACCINE. TWO DAYS AFTER THE PATIENT RECEIVED THE VACCINE, SHE EXPERIENCED A HARD, RED SPOT AROUND 3-4 INCHES IN DIAMETER SEVERAL INCHES DOWN FROM THE INJECTION SITE.  SHE DID NOT SEEK TREATMENT, AND THE SPOT DISAPPEARED AROUND 10 DAYS LATER. THE PATIENT DID NOT REPORT THIS TO THE PHARMACY UNTIL APRIL 29, 2019
Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR. Provider d/c note: "Patient, 62 yo non-verbal female with history of CVA, dysphagia, aphasia, hemiparesis, PEG tube, schizophrenia and diabetes who presented to the ER from her residential facility for concern of emesis and hypoxemia. She was found to be COVID+ with bilateral aspiration pneumonia. On initial presentation she was found to be septic with hypotension, tachycardia, leukocytosis and elevated lactic acid. She was initially requiring oxygen and decadron for hypoxemia however was able to wean off of the oxygen with good saturation on room air. Initially started on zosyn for aspiration pneumonia and was able to be transitioned to Augmentin for a 5 day course. She was able to resume tube feeds, tolerated well and oxygenation remained good and she was discharged back to her residential facility with continue supportive care for COVID and augmentin for aspiration pneumonia."
Patient has been experienced increased heart rate up to 135 for the last 4-5 days after getting her booster dose. Patient called pharmacy on 12/6/2021 at around 3pm stating that she has been experienced increased heart rate up to 135 for the last 4-5 days after getting her booster dose. Patient had history of heart surgery. Pharmacist recommended patient to see her cardiologist as soon as possible.
pt received an expired dose; This case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 62-year-old male patient who received HAV (Havrix 1440) (batch number 2BA 99, expiry date 16th December 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd December 2022, the patient received Havrix 1440 (intramuscular) 1 ml and Havrix Pre-Filled Syringe Device. On 23rd December 2022, unknown after receiving Havrix 1440 and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-DEC-2022 Reporter's Comment: The physician reported that the patient received an expired dose of Havrix into right deltoid. The reporter consented to follow up. Additional Supportive Information: The use of Havrix dose, which was already expired on 16th December 2022, which led to expired vaccine used.
At 10:00 P.M I begin to get hives all over my body. I had swelling all over my body. I had intense pain in my arm. I had golf side lump on injection site. The pain in my arm became so unbearable, I could not lift my arm. My blood count was all over the scale. I had bruises all over my body. In June diagnose with cancer. I had 2 different surgeries.
On 4/11 the patient started to have fatigue and HA. On 4/15 patient started to have rash, fever. 4/1823 patient tested positive for chicken pox.
SkinRash, Rash, UrticariaPruritus, Right underarm pain 1/4/21 Narrative:
Dizziness, nausea (Vasovagal).  Pts vital signs taken and monitored for 30 minutes.  Pts vital signs within normal limits; Pt skin PWD, Pt states she is now symptom free.  Pt declines need for further evaluation or transport by medical.
At 10:45 pm about 6-7 hours after receiving the vaccination at 2:10 pm I developed symptoms of tiredness, chills, and fever. I then slept roughly 9.5 hours. The symptoms continued until morning when I took some ibuprofen to help lower the fever. At 10:30 am I had a fever of 100.1 and at 12:45 pm I currently have a fever of 99.3. I feel as if I am gradually getting better.
Approximately 6 hours after the injection I began to experience tachycardia at rest. My resting heart rate increased to 115-120bpm. I had typical post vaccine symptoms such as muscle aches and fatigue but the tachycardia is the reason for this report. Tachycardia self-resolved at approximately 23 hours post vaccination.
Pt experienced a rash, soreness and bad joint pain. Pt also experienced a heart reaction.
Vaccine was administered to the patient after the beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was administered to the patient after the beyond use date) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was administered to the patient after the beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was administered to the patient after the beyond use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-218565, MOD-2021-218569.
tingling in feet, muscle weakness, hives, fever.  Eventually diagnosed with a subclinical case of Miller-Fisher Syndrome.   10/26/09: Discharge Summary received for Dates of Service 10/18/09 to 10/20/09.  Final Dx:  Possibly rare mild Miller Fisher variant of Guillain Barre syndrome.  Had flu shot 1 month ago. Assessment:  Admitted for generalized weakness and "funny feeling" in right knee.  Had LP at end of September, with same sx. as when she had a fall at end of Sept.  Neurology consulted.  Seen by neurologist on 10/7/09, neuro. exam WNL.  Nerve conduction velocity studies were OK on 10/15/09.  Borderline elevation in granulocyte GQ1B antibody for Miller Fisher variant of GBS.  Brisk tendon jerk on the knee, otherwise neuro. exam unremarkable.  No ataxia or gait problems.  Discharged to home to f/u with neuro. and PCP.  10/26/09 ICD 9 Codes Received:  357.0, 493.90. 12/22/09 Additional medical records received for DOS 10/07/09-12/09/09.(PCP and neurologist) Motor strength improving.
Systemic: blood glucose fluctuations-Medium, Additional Details: BLOOD GLUCOSE FLUCTUATIONS, BLOOD GLUCOSE LEVELS CONTINUE TO READ ABOVE GLUCOMETER MEASURING ABILITIES (EG: "HIGH" IS RESULT ON METER). PATIENT HAS FOLLOWED UP WITH PROVIDER TO INCREASE BOTH BASAL AND PRN BOLUS INSULIN. GLUCOSE LEVELS DECREASED TEMPORARILY BUT HAVE INCREASED AGAIN. RPH RECOMMENDED FOLLOW UP WITH PROVIDER.
Spotted rash began on face the morning of 6/20/2014.  Took her to doctors in which she confirmed it seems like the measles rash.  3 swollen lymph nodes in neck.  Next day fever of 100 going up to 101 x 3 days.  Rash became severe all over body by day 2 in which the rash on her face became so inflamed her lips and ears were swollen.  The rash on her face became one big red blister on both cheeks by day 3.  Severe itching for 5 days.  Severe congestion and "cold like symptoms" through the duration.  Rash and fever finally started to subside by day 5.
This spontaneous report was received from a doctor of pharmacy concerning a 69 year old female patient. On an unknown date (reported as years ago), the patient was vaccinated with a dose of PNEUMOVAX 23 (manufacturer unknown) (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. On an unknown date (reported as so many years ago), the patient experienced redness, swelling that was itchy at the injection site after receiving the vaccination. It was unspecified if the patient had sought any medical attention or any lab tests were performed. The patient was treated with a steroid, prednisone steroid pack (reported as PRED PACK). The patient had recovered from all the events on an unknown date. The relatedness for all the events was unknown for PNEUMOVAX 23 (manufacturer unknown). Additional information has been requested.
My daughter broke out in hives to left arm at injection site approximately 6 hrs after injection, site was itching, started as 3 hives and quickly became over 10, gave benedryl pill and hives went away over night, then came back in the morning about 9am, gave second dose of benedryl and hives were relieved and did not return. I reported traction to Pediatrician. Pt. has received the flu vaccine ever year since she was 1yrs of age and has never had an allergic reaction of any kind.
Tongue tingling  37 minutes after vaccine administration - was given 50mg diphenhydramine oral solution at pharmacy, mother then picked up patient and went to ED for further evaluation
had very bad symptoms and they are not well until today; This is a spontaneous report from a non-contactable consumer. A female patient (sister) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: not reported), via an unspecified route of administration on an unspecified date as UNKNOWN, SINGLE DOSE for covid-19 immunisation; covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), route of administration, start and stop date, batch/lot number and dose were not reported, for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient experienced had very bad symptoms and they are not well until today. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021703343 same reporter/drug/AE, different patient
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "recovered", described as "Dizzy". Additional information: States that 2  days ago she had her 2nd Pfizer shot and her 26-year-old granddaughter said to go home and don't do anything, just to go home and relax and get a good nights sleep and that she hopes she doesn't get sick like she was. During report caller states she personally knows of 2 people that have experienced dizziness after the shot but theirs went away. They both have the Pfizer COVID shot. One lady is a receptionist for her son and her mother in law was dizzy with the shot. She was worse than the caller but came back perfectly after going through it worse. Caller declines to report. States both had the Pfizer COVID vaccine. Expiry Date of Pfizer COVID shot: Not Provided. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received the flu vaccine on 12/15/17. On 12/17/17 pt began having left sided pain and then left sided numbness. Pt went to her local ER where she was treated and released.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 01Oct2023 as dose 1, single (Batch/Lot number: unknown) at the age of 72 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Chronic lymphpcytic leukemia" (unspecified if ongoing); "Mild asthma" (unspecified if ongoing), notes: Mild; "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: KLOR CON, start date: Aug2018, stop date: 01Nov2023; ACYCLOVIR [ACICLOVIR], start date: Aug2018, stop date: 01Nov2023. Past drug history included: Tetracycline, reaction(s): "Known allergies: tetracycline", Vaccination history included: moderna covid-19 vaccine (vaccine dose number=1, vaccine location=Left arm), administration date: 26Feb2021, when the patient was 70-year-old, for COVID-19 immunization; moderna covid-19 vaccine (vaccine dose number=2, vaccine location=Left arm), administration date: 26Mar2021, when the patient was 70-year-old, for COVID-19 immunization; covid-19 vaccine (vaccine dose number=3, vaccine location=Left arm), administration date: 03Sep2021, when the patient was 70-year-old, for COVID-19 immunization; bnt162b2 (vaccine dose number=4, vaccine location=Left arm), administration date: 26Apr2022, when the patient was 71-year-old, for COVID-19 immunization; bnt162b2, bnt162b2 omi ba.4-5 (vaccine dose number=5, vaccine location=Left arm), administration date: 24Oct2022, when the patient was 71-year-old, for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 23Oct2023 to 29Oct2023.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Pt manifested abdominal pain, vomiting, and decrease in appetite on 5/18/00. Pt also had a rash on anterior surface of both legs. Pt was brought to ER on 5/22 and admitted. Pt was given IV fluids due to dehydration. On 5/24, prior to discharge, pt complained of joint pain, rash on both thighs and arms as well as the abdominal area. She was dxed with hematuria and Henoch-Schonlein purpura. Pt received Children's Advil for the joint achiness.
pt recvd MMR 21OCT92 & devel fever 31OCT & 1NOV92 then rash the evening of 24NOV92; no further fever;
Swollen lymph node under left arm.  This remained until he got his second shot. He also had a strong response to the first shot with fever and headache. He tested positive for covid in January of 2021.
A ZOSTAVAX vaccine was given 12-1-15 by IM route instead of subcutaneous route. Patient is fine. We consulted with vaccine manufacturer and was told there is no need to revaccinate-effective and less side effects than subq.
This medically confirmed spontaneous report (initial receipt 24-OCT-2014) concerns a 40-year-old female patient. The patient was average in height and weight. The patient received flu vaccine before, however this was the first time he had adverse events. On 21-OCT-2014, the patient received AFLURIA (batch number T52108) via intramuscular route at 0.5 ml. On 23-OCT-2014, the patient experienced severe vertigo with symptoms of nausea, dizziness and feeling faint. The patient had no history of vertigo and found it alarming. ON the afternoon of 23-OCT-2014, the patient felt a little better but the vertigo persisted. HE did not seek medical treatment and had done nothing to treat it. The outcome was reported as not yet recovered.
was going to blackout; Body aches; headache; chills; nausea; Chest pain; This is a spontaneous report from a contactable consumer reported for self. A 54-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 2 via an unspecified route of administration, administered in Arm Left on 24Apr2021 20:30 (Batch/Lot Number: EW0153) as 2nd dose, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included Heart murmur. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient's concomitant medications were not reported. Historical vaccine included the first dose of BNT162B2 via an unspecified route of administration, administered in Arm Left on 01Apr2021 (Batch/Lot Number: EP7533) as 1st dose, single for COVID-19 immunization. On 25Apr2021 16:00, the patient experienced body aches, headache, chills, nausea and chest pain, chest pain was severe with chills, felt like she was going to blackout, her husband propped her up in bed, gave Advil and a cool rag for her head, temp was 98.3 Fahrenheit. Outcome of the events were unknown.  Follow up attempts needed. Further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak) and FALL (fell) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.  On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weak) and FALL (fell). At the time of the report, ASTHENIA (weak) and FALL (fell) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The treatment medicines relevant to events were not reported.
This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (I've got muscle soreness in my left arm /muscle soreness in my left arm /Pain has been consistent since the first dose/ache) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 001B21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (I've got muscle soreness in my left arm /muscle soreness in my left arm /Pain has been consistent since the first dose/ache). At the time of the report, VACCINATION SITE PAIN (I've got muscle soreness in my left arm /muscle soreness in my left arm /Pain has been consistent since the first dose/ache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.  It was reported that patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Patient received 3rd dose of the vaccine in his left arm. and still dealing with a side effect from some time ago patient had gotten 3 shots
pt recv vax 20DEC96 1230PM & pt became pale, sweating profusely & was in pain (both chest & jaw) & SOB;EMS transported pt to local hosp ER:BP was 1/2 nl 90/50;died 830PM;
Mild headache, mild nausea, fatigue, mild diarrhea, mild injection site soreness. These occurred within an hour after getting the injection. The side effects went away after a couple of days. Then a week after the injection, the injection site became suddenly sore, swollen, itchy and hot and still is as of today, 1/13/21.
Itchy rash developed on neck during the evening 1 day after the vaccine. Spread somewhat to my face and 8/1/21 spread to my chest.
Vaccine administered 6 hours after reconstitution...Contacted PFizer, CDC, ACIP and local epidemiologist Dr. advice was followed to consider dose give as valid and offer re-vaccination only if patient wanted.  Patient was contacted and expanded the issue offered advisement from Dr. and offered re-vaccination if wanted.  no adverse reaction s/p vaccination.
I had minor body aches for a day after receiving the vaccine. On 02/23/2023, I had a sore throat. I tested positive for COVID-19 on 02/24/2023. I contacted my primary care doctor, and they did not prescribe anything for me. I took TYLENOL, ADVIL, SUDAFED, AFRIN and MUCINEX to help with my symptoms. As of today, I continue to feel fatigued.
After 48 hours, patient noticed swelling at injection site and it was hot to touch and red in color. She developed a rash then. At this point it has started bruising 2 days later.
The pt experienced hives the evening of the vax, it progressively got worse spreading over entire body, then face swelled. The pt went to the ER. Treated with Prednisone.
sick; stomach upset; not feeling well; lightheaded; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), ABDOMINAL DISCOMFORT (stomach upset), MALAISE (not feeling well), DIZZINESS (lightheaded) and DIZZINESS (dizziness) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced ILLNESS (sick), ABDOMINAL DISCOMFORT (stomach upset), MALAISE (not feeling well), DIZZINESS (lightheaded) and DIZZINESS (dizziness). At the time of the report, ILLNESS (sick), ABDOMINAL DISCOMFORT (stomach upset), MALAISE (not feeling well), DIZZINESS (lightheaded) and DIZZINESS (dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Relevant concomitant medications was reported.  Treatment information was not provided.
I am having a symptom that my lymph node underneath my underarm area, it's swollen; it hurt to touch and even when I am raising my arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 17Dec2021 (Lot number: 330308D) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization; Bnt162b2 (Dose 2), for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "I am having a symptom that my lymph node underneath my underarm area, it's swollen"; LYMPH NODE PAIN (non-serious), outcome "unknown", described as "it hurt to touch and even when I am raising my arm".  No follow-up attempts are possible. No further information is expected.
One half hour after patient received H1N1 shot, he called back complaining of dizziness felt woozy and just did not feel right. Could not drive to MD so ambulance dispatched to evaluate.